1. Introduction
===============

Risk estimation in second-trimester prenatal screening for chromosomal anomalies, such as Down\'s syndrome (trisomy 21) or Edwards\'s syndrome (trisomy 18) is often based on the triple markers test.^\[[@R1]\]^ With this test, 3 maternal serum markers---namely, alpha-fetoprotein (AFP), free beta subunit of human chorionic gonadotropin (fβhCG), and unconjugated oestriol (uE3) are measured to estimate the pregnancies risks. For example, low concentrations of AFP together with increased fβhCG and low concentrations of uE3 are frequently found in women carrying Down syndrome fetuses.^\[[@R2]\]^ A separate screening protocol identifies some cases of trisomy 18, which is associated with low concentrations of AFP, fβhCG, and uE3.^\[[@R3]\]^ Therefore, effective and accurate screening relies upon the establishment of the median concentrations of AFP, fβhCG, and uE3 in pregnant women. The median equation plays a crucial role in the risk assessment of prenatal screening.^\[[@R4]\]^ Inaccuracy in equation settings can directly lead to inaccurate screening risk values, leading to the low detection, and high false positive rate of birth defects such as Down\'s syndrome.

Maternal serum analytes, AFP, fβhCG, and uE3 values have been shown to be influenced by gestation, maternal weight,^\[[@R5]\]^ race, and ethnicity,^\[[@R6]--[@R8]\]^ the presence of certain conditions like insulin-dependent diabetes,^\[[@R8]\]^ and smoking.^\[[@R9]\]^ As the levels of the 3 markers change with gestational age and body weight, the results of these markers are expressed as multiples-of-median (MoM). These MoM values are compared with parametric population statistics and combined with a prior risk based on maternal age to calculate the likelihood of chromosomal aneuploidy and neural tube defects (NTD).^\[[@R10]\]^ It is suggested to keep median MoM levels close to the target by making changes to remove biases which will continue.

The built-in median equations for the risk assessment software are based on Caucasian population, which affects the accuracy of screening results in China due to the intrinsic difference between Chinese and Caucasian population. To study and optimize MoM specific for Chinese population, adequate screening sample size and institutions with adequate annual screening sizes are important. In this study, we analyze screening data from 13 institutions in China in order to evaluate localization of the median equation in this population, improving accuracy of prenatal screening for chromosomal anomalies.

2. Material and methods
=======================

2.1. Research subjects
----------------------

This study was carried out at 13 screening laboratories in China as shown in Figure [1](#F1){ref-type="fig"}. All pregnancies are singleton, nondiabetic, and nonsmoker pregnancies with normal outcomes only. Data was collected at 98 to 146 days of gestation for test referrals to our laboratories from January to December, 2015. Prenatal screening involved 353,065 subjects in total. All pregnant women volunteering to participate in prenatal screening were counseled about triple testing and signed the informed consent.
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This study was approved by the Hospital Ethics Review Board and the approval number is Batch 2014, No. 042.

All the basic information of pregnant women including the date of birth, the last menstruation, body weight, date of prenatal screening, the number of fetuses, smoke history, type I diabetes mellitus history, and pregnancy history were collected.

2.2. Prenatal screening
-----------------------

Maternal plasma samples (2--3 mL) were collected from all pregnant women. The concentration of AFP, fβhCG, and uE3 were detected by time-resolved fluoroimmunoassay. AFP and fβhCG results were expressed in IU/mL and uE3 in nmol/L.

2.3. Statistical analysis
-------------------------

Data derived from 353,065 serum samples was examined in this study. Data were organized by using Microsoft Excel (Microsoft Corporation) and the gestational age and body weight of all pregnant women were analyzed by SPSS 17.0 software (SPPS Inc.). Median values for second trimester maternal serum markers were established as described by Vranken et al.^\[[@R1]\]^ Least squares regression was used to establish median equations of AFP, free βhCG, and uE3 by R language against gestational age (in days) and maternal weight and the fitting effect of median equations were judged by the corrected determination coefficient (*R*^2^). Based on the established median equations, MoM of each values were calculated and compared with the latest DQASS standards. Moreover, MoM determined the risk of carrying a fetus with trisomy 21, trisomy 18, and NTD by Wallace LifeCycle Elipse risk calculation engine (Perkin Elmer).

3. Results
==========

3.1. Data acquisitions
----------------------

This study employed data from 353,065 pregnant women in the second trimester, excluding multiple pregnancy, type I diabetes, smoking, poor pregnancy history, and abnormal pregnancy outcomes. As shown in Table [1](#T1){ref-type="table"}, Fujian Provincial Hospital (FPH), Fuzhou General Hospital Affiliated to Nanjing Military Region (FGH) and Nanping City First Hospital (NCFH) had \<5000 screening tests, while the other 10 prenatal screening institutions had annual screening capacities of more than 20,000. The average age of pregnant women at screening institutions was 27.36 years old with the average body weight of 54.33 kg. The average gestational days were 118 to 124 days with small standard deviations among different institutes.

###### 

Descriptive statistics of 13 prenatal screening institutions in Fujian Province in 2015.

![](medi-97-e12045-g002)

3.2. AFP, fβhCG, and uE3 median distribution with gestational age
-----------------------------------------------------------------

The medians of 3 serum markers, AFP, fβhCG, and uE3, were calculated and the median distribution among all the screening institutions was analyzed with gestational days. The results are shown in Figure [1](#F1){ref-type="fig"}. Compared with other 11 prenatal screening institutions, there is a significant difference in all 3 types of median values from FGH and NCFH. This discrepancy may be related to small number (839 and 1287) of screening tests done in FGH and NCFH. Therefore, data from both screening agencies were excluded for subsequent fitting of the median equations.

3.3. Median equations of AFP with gestational age and body weight
-----------------------------------------------------------------

As shown in Figure [2](#F2){ref-type="fig"}, we can see that the median equations fitted by AFP values from each screening institution have high consistency, which is different from the built-in median equations of LifeCycle risk assessment software. As can be seen from Table [2](#T2){ref-type="table"}, *R*^2^ of each equation is \>0.95, indicating that the data from all the screening institutions have good stability and the fitting effect of the median equations. *R*^2^ of the median equations from all data with gestational days and body weight are both 0.998. The details of the parametric equation are shown in Table [2](#T2){ref-type="table"}.
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###### 

Median equations and determination coefficient of AFP from 11 prenatal screening institutions.
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3.4. Median equations of fβhCG with gestational age and body weight
-------------------------------------------------------------------

As shown in Table [3](#T3){ref-type="table"}, *R*^2^ for the median equations of the fβhCG from each screening institution ranges from 0.904 to 1.000, indicating that the parametric equations among the screening institutions have some differences, which may be related to the fact that fβhCG is not stable. As can be seen from Figure [3](#F3){ref-type="fig"}, the median equations for the fβhCG, which differ from the median equation built into the LifeCycle risk assessment software, fit for each screening agency. *R*^2^ of the median equations from all data with gestational days and body weight are 0.998 and 0.994, respectively.

###### 

Median equations and determination coefficient of fβhCG from 11 prenatal screening institutions.
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3.5. Median equations of uE3 with gestational age and body weight
-----------------------------------------------------------------

As can be seen from Table [4](#T4){ref-type="table"}, *R*^2^ range of the median equations of uE3 from the 11 screening agencies is 0.832 to 0.995, indicating that there is a difference in the median equations from each screening agency. As shown in Figure [4](#F4){ref-type="fig"}, the median equations of uE3 concentration with gestational days have a significant difference from the built-in median equation of the LifeCycle, while the difference of the median equation of body weight is small. However, *R*^2^ of the median equations from all data with gestational days and body weight are 1.000 and 0.993, respectively.

###### 

Median equations and determination coefficient of uE3 from 11 prenatal screening institutions.
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3.6. The evaluation of the application effect of median equation obtained from large sample data
------------------------------------------------------------------------------------------------

Based on the median equation fitted by large sample data in Fujian Province, the MoM and MoM median of 3 kinds of serum marker in each screening institution were calculated. The detailed results are shown in Table [5](#T5){ref-type="table"}. Except FGH and NCFH, the MoM median values of other 11 screening agencies range from 0.95 to 1.05, of which 97.0% (64/66) are in line with the latest MoM prescribed by DQASS.

###### 

Retrospectively calculated median MoM from large sample median equations.

![](medi-97-e12045-g009)

This shows that the equations obtained from the big data of each marker can reflect the median level of each institution and can be used to replace the built-in equations of LifeCycle software.

4. Discussion
=============

The NHS Fetal Anomaly Screening Programme (FASP) has published a standard for quality assurance of MoM in Down\'s syndrome screening.^\[[@R11]\]^ Down\'s syndrome quality assurance support service (DQASS) is based on an analysis of a large number of UK data and proposes a universal standard for prenatal screening for MoM median analysis, with the whole world recognition. The recently updated standard specifies that "The median of the MoM values used in risk calculation, for any subpopulation defined by time period, gestational age, maternal weight, smoking status and ethnicity should lie within 5% of the target value of 1, that is, the median adjusted MoM value should lie between 0.95 and 1.05."^\[[@R11]\]^ To achieve this standard, it is recommended that laboratories monitor a whole range of different parameters to ensure that when median recalculation is necessary this will be carried out with a minimum of delay, thereby ensuring compliance with the standard.

At present, maternal serological screening is still the mainstream to monitor and prevent 21 trisomy syndrome, 18 trisomy syndrome, and NTD in China. To improve the quality of screening and to establish effective quality control standards, accuracy for prenatal screening are hot topics prenatal screening experts and the major screening agencies in China.^\[[@R12],[@R13]\]^ A number of studies have shown that the median levels of 3 serum markers, AFP, free β-hCG, and uE3, have ethnic and regional differences. Moreover, the main screening institutions in China use prenatal screening risk assessment software developed abroad, such as LifeCycle and 2T. Therefore, the localization of the median equations for prenatal screening risk assessment software is of particular importance.

This study included 353,065 cases of normal pregnant women in 13 screening institutions in Fujian Province. The sample size was much larger than the previous median equation studies. Ten screening institutions screened have more than 20,000 cases, which better represents the normal population level in all regions of Fujian Province, China. Meanwhile, all the screening data of AFP, free fβhCG, and uE3 concentration were measured by time-resolved fluorescence immunoassay and the maternal risk probability were calculated by LifeCycle software. All the above information is to ensure that the representation, accuracy, and reliability of the screening data in Fujian Province, China.

From Figures [2](#F2){ref-type="fig"} to 4, it is shown that the median equation of gestational age and weight fitted by the large sample data have high consistency with the one fitted in each screening institution, but the curve of the median equations from built-in LifeCycle deviates significantly from the localized equation. As shown in Tables [2](#T2){ref-type="table"}--[4](#T4){ref-type="table"}, under the condition of large sample data, the determination coefficients of the median equations of each marker are all \>0.99. The MoM median of each serum marker is calculated by the localized median equation, among which, excluding institution 6 and 7, 97.0% MoM medians (shown in Table [5](#T5){ref-type="table"}) meet the latest DQASS standards.^\[[@R11]\]^ These results indicate that the median equations of screening agencies are very well fitted. The larger the sample data, the better the fitting effect of the median equations and the more representative the median equations are.

Several studies have found that the median equations after localization for prenatal screening risk assessment software such as LifeCycle can increase the detection rate of trisomy 21 and reduce the false-positive rate, with overall better results than the median equations without localization, which can effectively prevent and control the birth of children with birth defects such as trisomy 21.^\[[@R1],[@R13],\]^ At present, many regions in China have achieved the median equation localization. However, due to the limited amount of prenatal screening data and the factors that affect the stability of the experiment, the localization of median equations in many prenatal screening institutions still cannot be achieved. In view of this, the median equations fitted in this study can be used in Fujian province, China to replace the median equations built-in the software, and can provide a reference and scientific basis for the regions where the median equation is not localized yet.
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